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Abstract
Objective: This research study aimed to explore pharmaceutical waste prevention and
disposal practices in nurse populations.
Methods: A descriptive, cross-sectional survey was employed through the Qualtrics survey
system. The survey questions were designed to probe knowledge, behavior, and attitudes
of nurses towards pharmaceutical waste. Participants included intensive care unit nurses
and perioperative nurses in the Yale New Haven Health System.
Results: A total of 104 surveys were collected. Nurses were asked about the importance of
proper waste disposal, and 95.2% of nurses (N=99/104) believed that appropriate waste
disposal is important to “protect the environment health.” The survey also asked about the
top reason that contributes to improper waste disposal practices, and 56.7% of nurses
(N=59/104 believed that the “lack of knowledge about waste segregation” is the top reason
for improper disposal practices. Nurses were also asked about reasons that contributed to
avoidable waste, and 37.5% of nurses (N=39/104 indicated that “the order for medication
that is less than the available package size” is the top reason contributing to avoidable
waste.
Conclusion: The survey uncovered a considerable gap in nurses’ knowledge of
pharmaceutical waste management and shed light on specific behaviors that can potentially
lead to improper disposal practices. Findings of this research study suggest that the
implementation of pharmaceutical education and training may result in waste prevention
which in turn could improve waste impacts on the environment and public health.
Keywords: pharmaceutical waste disposal; waste prevention, nursing education;
environmental contamination, YSPH Environmental Health Sciences
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Chapter 1: Introduction
Purpose of Study
According to the United States Environmental Protection Agency, hospitals
generate up to 15,000 tons of pharmaceutical waste per year (EPA, 2015).Health care
facilities must ensure that pharmaceuticals are disposed of correctly to stay within
compliance of regulatory agencies. There are many challenges to achieving proper
waste disposal, due to complex federal and state regulations, intended to protect
patients, occupational groups, and the environment. Gaps in drug disposal mandates
exist, and regulations do not explicitly cover certain types of drug waste. In response
to the differences at the regulatory level, hospitals and institutions have developed
individual waste systems to handle healthcare waste that is not addressed by
regulations. The complex regulatory milieu is very confusing, therefore, and improper
waste management behaviors are common. At the occupational level, additional
challenges include variable adherence practices among individuals for proper waste
management, creating further confusion between staff.
Regulatory agencies play a significant role in the development of
protocols for drug waste management. More specifically, drug disposal
practices should follow specific protocols such as those in place for controlled
substances from the Drug Enforcement Administration, Resource Conservation
and Recovery Act, and the Environmental Protection Agency. However, many
pharmaceuticals not within such protocols are state regulated, which may
contribute to gaps in clinical waste management. To streamline the waste
management of drugs, hospitals can implement local procedures to protect the
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environment. Furthermore, to be in compliance, and meet production
pressures, nurses may be engaging in practices that result in unnecessary
disposal of an unused drug due to regulatory complexity, production pressures,
and/or lack of awareness for public health impact. One goal of this project is to
encourage pharmaceutical management policies and procedures that promote
waste prevention, in addition to proper waste disposal methods.
This investigation explores nurse attitudes and behaviors about pharmaceutical
drug waste at Yale New Haven Hospital (YNHH). Moreover, the study explores
attitudes toward pharmaceutical management policies and procedures to understand
better how to optimize drug stewardship at the health professional level. Its goals are
to understand drug waste from the occupational perspective of pharmaceutical waste
administration, focus on quality improvement of waste management, and explore
methods for waste prevention. The results of this thesis may inform policy or practice
reform to allow for more streamlined drug waste methodologies and prevention
techniques for medical personnel, administrators, and regulators (OSHA Drug Manual,
2018).

Significance of this Project
The United States healthcare sector is accountable for ten percent of the
nation's greenhouse gases. Hospitals produce an appreciable amount of pollution:
anesthetic gases that tear through the ozone layer, pharmaceutical drug waste that
affects water sanitation and social health and foods that are unsustainable for the
environment. For this reason, these institutions are interested in making systemic
changes. The significance of waste prevention offers the opportunity to cut costs and
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cut impacts on the environment. Additionally, due to the large influx of pharmaceutical
waste, the prevention of pharmaceutical disposal could be another The prevention of
pharmaceutical waste is an encouraged and necessary action for institutions
developing waste due to the multiple methods of disposal and treatment which may
lead to increased adverse effects on health and environmental issues. It is imperative
to decrease pharmaceutical waste because of the impacts on costs, more importantly,
impacts on environmental and public health. (EPA, 2014).
Currently, the FDA approves an average of thirty new drugs each year. The
United States alone invests about eighty-six billion dollars into research and
development. With the high demands of healthcare structure and innovation, the global
industry expects at least one thousand new drugs on the market by 2050 (Kepplinger,
2015). Pharmaceuticals enter the environment via consumers, pharmacological trials,
hospitals, and agriculture/aquaculture fields. More explicitly, the increase in
pharmaceutical drugs in hospital and clinical settings is concerning for the environment
and public health due to the increase in the disposal.

Chapter 2: Background of Study

Pharmaceutical Waste Management
Because of the different classes of drugs that are opened and prepared,
different types of disposal treatment methods are required for safe management.
Pharmaceutical waste consists of any pharmaceutical product (drug and delivery
systems including needles, syringes, tubing, bags, etc.) designated for discard. The
types of disposal classes include controlled substances, hazardous waste, non-
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hazardous waste, and chemotherapy waste. (See Figure 1). The Department of
Energy and EPA define hazardous waste as: ignitable, corrosive, reactive or toxic.
Among these are antibacterials, antibiotics, endocrine disruptors, plasticizers, steroids,
and other anti-metabolites. Hazardous waste includes P-Listed (acutely toxic
chemicals), U listed (toxic chemicals), and D- Listed (characteristic hazardous waste).
(Figure 2). (Paone, Vogenberg, & Caporello, 1996).
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Regulatory Agency Role in Pharmaceutical Waste
Pharmaceutical waste cannot be disposed of like general waste and requires
handling that adheres to regulatory agency protocols. In 1976, the Resource
Conservation and Recovery Act (RCRA) was established which governed the
management of solid and hazardous waste generated within the United States.
Management of pharmaceutical waste further differs on a state by state basis (Doerr &
Haight, 2006). Also, the Drug Enforcement Administration (DEA) oversees waste
management of controlled substances, to further ensure prevention of “diversion” for
resale/reuse. Finally, many pharmaceutical products are not covered by these
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guidelines, and are state and/or facility-regulated (Buszska et al., 2009).
The complexity and lack of consistency in protocols for pharmaceuticals lead to
confusion and gaps in knowledge about proper waste disposal. Table 1 shows the
breakdown of key stakeholders involved in pharmaceutical waste management. There
are disparate regulations across the United States. One example is that the current
Connecticut Pharmaceutical Waste Stream allows for an intravenous solution such as
saline to be disposed of through the sewer system. This type of waste management is
through the state Publicly Owned Treatment Works (POTW), and institutions need a
discharge permit to allow for this type of disposal. However, in Wisconsin, it is not
permitted to dispose of saline through sewer systems and fines could result for
institutions caught disposing of such materials through this method (UWG, 2015).
Improvements in the understanding of procedures and policies are critical. (Bound,
Kitsou, & Voulvoulis, 2006).

Policies Requiring Specific Disposal Pathways
Controlled substances and Drain Disposals
Controlled Substances are drugs or chemicals whose manufacture, possession,
or use is regulated by the Drug Enforcement Administration (DEA. The DEA proposed
the Controlled Substance Act (CSA) which requires that controlled substances must not
be in reach for reclamation, and two professionals must document destruction. For
controlled substances, drain disposal is the most common method for removal to ensure
the drugs are unrecoverable. The DEA mentions the following schedules for controlled
substances:
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1. “Schedule I includes drugs that have no accepted medical use, such as heroin.”
2. “Schedule II drugs are used medically but have high abuse potential, such as
morphine, and their purchase, storage, and use requirements are very strictly
monitored.”
3. “Schedules III through V are drugs with decreasing abuse potential, all the way
from sedatives to cough suppressants, such as codeine.” (DEA, 2014)
Under certain circumstances, there is an exclusion that allows drain disposal of
P-listed wastes. This depends on the size of the waste generator and how the waste
enters the sewage system (HERC, 2016). This also includes certification of a program
in place to reduce volume and toxicity of hazardous wastes generated (DEA, 2014) the
drain disposal method is causing more complications for publicly owned treatment plans
and regulatory agencies like the USEPA are discouraging this method (Rannazzasis,
2014).
Regulatory agency mandates for treatment of unused pharmaceuticals are
intended to protect the public from inadvertent poisoning. In some cases, flushing
unused pharmaceuticals down the toilet or throwing them down the drain was
considered the safest and simplest way of disposal. However, the consequences on the
environment and its potential impacts on public health are revealing environmental
concerns such as polluted water streams and impacted ecosystems.
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Table 1: Regulatory Agencies governing pharmaceutical waste disposal
Agency
Environmental Protection
Agency
(EPA)
Department of Transportation
(DOT)

Drug Enforcement
Administration
(DEA)

Occupational Safety & Health
Administration
(OSHA)

Description
EPA establishes cost- saving, streamlined standards for handling hazardous waste pharmaceuticals to fit the
operations of the healthcare sector better while maintaining protection of human health and the environment.
while maintaining protection of human health and the environment. Enforces Clean Air Act, Clean Water Act,
Resource Conservation & Recovery Act (RCRA), and Toxic Substances Control Act (TSCA)
DOT regulates personnel training, packaging, and transporting requirements related to hazardous materials;
these regulations are also enforced by the Federal Aviation Administration with regard to shipping specimens.(49
CFR 171, 172, and 173:)

DEA Enforces Controlled Substances Act (CSA) which provides a mechanism for substances to be controlled
(added to or transferred between schedules) or decontrolled (removed from control). Among other aspects
relative to controlled substances, this act regulates their disposal (Disposal of Controlled Substances)
OSHA Regulates several aspects of medical waste, including management of sharps, requirements for containers
that hold or store medical waste, labeling of medical waste bags/containers, and employee training. These
standards are designed to protect healthcare workers from the risk of exposure to blood-borne pathogens.
However, they also help to systematically manage wastes, which benefit the public and the environment.

State Environmental Protection
Agency

Nearly all 50 states have enacted medical waste regulations to some extent. Most states have regulations
covering packaging, storage, and transportation of medical waste. Some states require health care facilities to
register and/or obtain a permit. State rules may also cover the development of contingency plans, on-site
treatment, training, waste tracking, recordkeeping, and reporting.

Local Publicly Owned Water
Treatment Works
(POTW)

POTW manage the materials being flushed or poured down the drain. There are restrictions on types of
chemicals (including pharmaceuticals), blood and other materials. POTW is managed locally, though, they are
bound by Federal EPA standards under Water Division and often further regulated by State regulatory agency

Source: Healthcare Environment Resource Center
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Pharmaceutical Processing Pathways
Disposal and treatment is a primary source of environmental contamination by
pharmaceuticals (Bottani et al., 2010). Once pharmaceuticals enter into the disposal
stream, hospital environmental safety officers must ensure the proper management.
All approaches must consider the environmental, financial, and technical application of
treatment and disposal technologies (WHO, 1999).
All waste disposal and treatment methods have impacts on health and
environment (EPA, 2014). Improper disposal of pharmaceuticals may be hazardous if
it leads to contamination of water supplies used by nearby communities (WHO, 1999).
Additionally, burning pharmaceutical waste at low temperatures or in open containers
releases toxic pollutants into the air (EPA, 2014). The US EPA mentioned that medical
waste incineration is the largest source of dioxin air pollution (US EPA, 1997).
Pharmacaeutical waste dumped in could create the possibility of leachate entering an
aquifer, surface water or drinking water system. Treatment and disposal processes
must consider the impacts on the environment and public health.
Furthermore, treatment and disposal methods can create significant costs on
waste compliance fees (EPA, 2014). In most cases, waste companies charge for
biomedical waste by the pound, and as mentioned, hospitals can create up to 15,000
tons per year; therefore, disposal fees can amount to hundreds of thousands of dollars
each year. Waste prevention is not only significant for decreased sources of
contamination, but it also proves to be another important reason for saving on costs
(EPA, 2014). .
There are five waste different treatment methods, depending on the type of
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drug classification as shown in Figure 3. These include incineration, autoclaving,
microwave, chemical treatment, and landfill. The ideal aim for better waste stream
systems and prevention methods should adhere to the triple bottom line: reduce costs,
protect ecosystems, and prevent adverse health outcomes from environmental
impacts.
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Table 2: Pharmaceutical Waste Treatment and Disposal (Stericycle 2018 and EPA 2017):
Method

Incineration

Description

Environmental/Health
Impact

The burning of waste at
high temperatures (800900 °C) under oxygenstarved conditions.

Residual ash is land-filled,
and can cause soil, air and
water contamination.

Capital Costs

Handling for Each Type of Drug

$2000-$100,000

Bulk and Trace Chemotherapy
Pharmaceuticals

$36,000– $889,000

Red Bag (Non-pathology)
Red Sharps (Needle Bag)

Water emissions occur
when wet scrubbers are
employed to remove
particulates
Burning of fossil fuels can
result in air pollution (e.g.,
particulate matter 2.5)

Autoclaving

The steam heat of at
least 121°C, combined
with pressure are used
to destabilize drugs and
decontaminate
associated sharps (e.g.,
needles).

After autoclaving, waste
goes to landfill. Waste can
result in soil and land
contamination through
leaching of residual
compounds.

Contamination of water can
Heat transfer penetrates occur from effluent.
the waste load.
Shredding will increase
the exposure of waste to
treatment, render sharps
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“unrecoverable,” as well
as reduce waste volume.
***Byproduct can be
landfilled

Microwave

This process uses
radiant energy to heat
moisture within the
waste and/or heat water
that is added to the
waste. Microwaving units
kill infectious agents and
drugs through heat and
pressure, not as a result
of exposure to the
microwaves.

After microwaving, waste
goes to landfill. Waste can
result in soil and land
contamination through
leaching of residual
compounds.
.

$600,000

Bulk and Trace Chemotherapy
Pharmaceuticals
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Chemical Treatment

Chemicals are
introduced into a
sterilization chamber.
With proper exposure
conditions, waste is
sterilized before going to
landfill

Sewage treatment
processes can be
negatively impacted by
residual chemical
compounds in waste water
effluent.
.
With some chemical
systems there is potential
soil contamination in
landfills.

Landfill

Landfills place waste
directly into a land
disposal site without
prior treatment or
preparation. Three types
of landfill:
1)Open uncontrolled
non-engineered dump

“One half of available
--------carbon is converted to
methane during
degradation. Methane is 25
times more destructive to
the ozone layer than carbon
dioxide.”

2)Engineered landfill
3) Highly engineered
sanitary landfill

Landfill must be monitored
to prevent contamination of
ground water.
Must remove materials
containing lead and
mercury from landfills to
decrease leachate in soil
and water

30,000-450,000

Bulk and Trace Chemotherapy
Pharmaceuticals

Red Bag (Non-pathology)
Red Sharps (Needle Bag)
Municipal Trash
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Impacts on Public Health
Pharmaceuticals are developed to intentionally resist biodegradation, which can
impact public health. One study conducted by the U.S. Geological Survey found
prescription and nonprescription drugs in about 80% of 139 streams in the United
States (USGS, 2014). Moreover, the National Resources Defense Council reported in
2008 that pharmaceuticals are present in public drinking water supplies serving over
forty million Americans across the United States (NRDC, 2010). In a current research
study from the US Geological Survey, the national impact report of water supplies
noted that hospitals are the critical drivers and sources of contamination by hazardous
drugs. The wide range of pharmaceuticals detected in waste waters, surface water,
groundwater, and drinking water creates a public health issue due to the potential for
transfer to a human directly and indirectly (USGS, 2014). These impacts show the
necessity for pharmaceutical policies and procedures that better adhere to drug
stewardship in the form of waste prevention and proper disposal.

Impacts of Pharmaceuticals in the Environment
Due to the pervasiveness of pharmaceuticals in the environment and concern
for environmental exposures, drug stewardship is a significant topic for hospitals, which
are primary drivers of drug utilization and waste (Zuccato et al., 2006).
Pharmaceuticals differ from other environmental pollutants in that they are developed
to be biologically active and these chemicals will interact with cells following the
properties of absorption, distribution, metabolism and excretion (Fatta-Kassinos et al.,
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2011). Though these properties are useful at the therapeutic level, they can have
adverse effects in uncontrolled situations. Proper disposal and management, and
waste prevention are necessary to minimize the detrimental impact of pharmaceutical
waste on the environment.
The negative impact of pharmaceuticals on the environment originates from the
chemical effects of pharmaceuticals on the environment. Over six hundred different
pharmaceutical agents and their metabolites are detected in seventy-one countries on
all continents (Zhou et al., 2009). Ultimately these impacts can contribute to
environmental problems, such as polluted water systems, contaminated soil, polluted
ecosystems, and the emergence of resistant pathogenic bacteria (Donn et al., 2009).
The number of pharmaceuticals detected water sources is rapidly increasing.
Pharmaceutical drugs have negative impacts on aquatic species due to their
susceptibility to toxicity effects. Aquatic species may serve as proxies for the human
health impacts of environmental exposures. Detrimental effects on fish populations are
consequences of pharmaceutical pollution and link to changes in energy metabolism,
mitochondrial activity and reproductive failure. (Manuel et al., 2010). For example, one
animal toxicology study demonstrated that the runoff of drugs like Prozac caused
aquatic life such as crustaceans to undergo behavior changes such as abnormally
swimming towards the light, leading to more significant exposure to phototoxic effects.
(Rodriguez-Mozaz & Weinberg, 2010).The ubiquitous prevalence of pharmaceutical
drugs poses long term and short term impacts. Long term impacts include skewed sex
ratios among fish due to excessive hormone levels in water and short term impacts
include contamination of water quality by eutrophication. Eutrophication is the impact
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on the water by nutrient salts that causes changes in the ecosystem such as the
depletion of fish species, deterioration of water quality and increased production of
algae and plants. When medicines are prescribed in response to an acute or chronic
illness, only a portion may be metabolized, and the non-metabolized portion (Active
Pharmaceutical Ingredients (API). Both metabolites and APIs can enter the
environment through wastewater effluent and landfill soil routes. While doses may be
“sub-therapeutic,” there is growing concern about micro-exposures during key human
development stages, as well as to unknown synergistic effects from multiple
exposures.

Limited Research on Chronic Health Exposure
There is limited research on chronic health exposures and trace amounts of
Active Pharmaceutical Ingredients in the environment. Many factors contribute to the
limited research, such as the validity of using wastewater treatment plants as
pharmaceutical waste detection sites, the presence of low levels/trace amounts in
water, and the overall lack of evaluation of health risks (Cabello, 2006).
Pharmaceuticals entering wastewater treatment plants are not transformed or
removed, as such treatment technologies (e.g. reverse osmosis) are not implemented.
Therefore, these chemicals are likely to be present in the effluents at high levels
(Kemper, 2008). Wastewater treatment plants are identified as the main points of
discharge of pharmaceuticals into surface waters and could assist with chronic health
exposure research. However, the adequacy and efficiency of these plants as study
sites have not been explored. (Chenxi, Spongberg, & Witter, 2008)
Since pharmaceuticals are now routinely found in the environment at low or
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trace levels, there is a need for further exploration on lasting impacts. For example,
one study monitoring drinking water found the presence of sixteen pharmaceutical
compounds (Nassiri & Abdollahi 2017). The human health risk assessments showed
low levels of risk; however, the chronic effects are not clear due to the limited
exposure time. Another study exploring pharmaceutical waste in tap water in China
found seventeen active drugs. However, thirteen of the drugs were deemed to be low
risk, and four were found to have at least one life-stage risk, which could be
threatening to infant and child life stages. The researchers proposed the need for
more research and proposed an indicator-based monitoring framework to better
identify the source (Leung et al., 2013). Though several studies are concluding low
health risks, there is a necessity for chronic exposure research and analysis of lowdose of pharmaceutical waste at a high interval (pseudo persistence) (Donn et al.,
2008).
The amount of environmental data for pharmaceuticals is not sufficient to make
definitive associations. Many pharmaceutical studies focus on “single grab samples”
which do not adequately capture variation and may not represent actual
concentrations (Leung et al., 2013). Instead, representative sampling including spatial
variability concerning land and drug use and temporal variability should be explored.
Additionally, pharmaceuticals represent several hundred chemicals which could also
be a factor in limited chronic exposure, and this is a challenge for researchers to study
source characterization and exposure assessment. Though most pharmaceutical
companies offer physicochemical data on specific pharmaceuticals, exposure
assessment is still a challenge due to the toxicology of mixtures and complicating
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factors such as unknown soil-water partition, biodegradation rates and distribution
coefficients (Rodriguez & Weinberg, 2010).There is a need for longer-term research
on the chronic exposure of drug waste, and it is an evolving concern due to the lack of
long-term exploration for these compounds. The impact of pharmaceutical waste on
health systems is an area in epidemiology and toxicology where research is critical
(Leung et al., 2013).

Intersection of Occupational Health and Pharmaceutical Waste Management
Nurses are vital contributors to the generation of, and disposal of pharmaceutical
waste. Nurses play one of the most active roles in pharmaceutical management given
their profession to administer and dispose of patient medicines. Additionally, nurses
work across patient and community settings where medications are stored, monitored
and eliminated (Practice Green Health, 2016). However, universal management
guidelines may not always be available or taught at nursing school. Often, nurses may
engage in practices that result in unnecessary drug waste generation as well as
improper disposal due to regulatory complexity, production pressures, and ignorance of
public health impacts of their behaviors. Nurses generally do not receive training on
hazardous waste management during their studies and may not be familiar with active
ingredients. To combat these gaps in knowledge, the American Nurses Association
(ANA) adopted a policy to describe nurses’ role in pharmaceutical waste generation and
disposal (Stanton, 2011). The ANA policy also adds education and supervision to the
framework to promote proper use and disposal in the community (Murphy et al., 2013).
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Unused and Unavoidable Pharmaceutical Waste
The phrase “drug waste” may be confusing, as it refers to the act of disposing
of unused drugs, the substance itself being disposed of, and furthermore whether the
unused drug is avoidable. In some cases, unused drug waste is unavoidable; for
example, if a patient gets better and no longer needs infusions. Unavoidable
pharmaceutical waste may be generated through different processes in a healthcare
facility including, but not limited to, the following: the patient's medical condition has
been resolved, the medication causes an adverse effect and must be discontinued,
physicians switch medicine due to new information, or the patient dies (Walters,
1992).

Avoidable Pharmaceutical Waste
Often, the generation of an unused drug is avoidable. Protocols and behaviors
contribute to significant drug waste due to factors both intrinsic and extrinsic to
hospitals or clinics. This is inclusive of a complex federal and state regulatory milieu
that mandates drug packaging, preparation, administration, expiration, and disposal
procedures intended to protect patients, occupational, and environmental safety.
Additionally, regulatory gaps filled by local policies to achieve regulatory compliance
and occupational work flow including production pressures that drive expedient
compliance (HERC, 2016). Figure 4 shows the most common situations that create
avoidable waste including error in provider orders, changes in provider orders,
expiration of an open drug, production pressures leading to changing infusions
prematurely, and the order for medication is less than the available package size.
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Behaviors and Policies Contributing to Hospital Drug Waste and Pathways
Avoidable waste is a large component of pharmaceutical waste; however, there
are many behaviors and policies not included. This section focuses on avoidable waste
by highlighting behaviors such as medication error and specific policies that call for
wasting pharmaceuticals (American Society of Consultant Pharmacists, 2014). The
exploration of behavior and system can offer insight into where and when hospital drugs
are spent and how certain drugs must be wasted according to protocol.
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Behaviors and Procedures Impacting Hospital Drug Waste
Dispensing Error
Dispensing errors can occur when pharmaceuticals are administered and
delivered by the pharmacy or medicines are supplied by drug dispensing machines (like
a Pyxis machine), and are inaccurate (Uribe et al., 2002). For example, some of these
errors include labeling errors, the wrong quantity of a drug, wrong dose, duplication,
wrong drug, wrong dosage form, and wrong patient. The impacts of dispensing error are
to increase pharmaceutical waste in the department and according to Joint Commission
on Accreditation of Healthcare Organization standards, once the pharmaceutical is
dispensed “to the floor” the medicine can no longer be sent back to the pharmacy if it is
incorrect (HCPR, 2003), thus resulting in an automatic waste (Hughes & Blegen, 2008).
Standardized Timing
Standardized timing of drugs may not fall conveniently within nursing shifts, or
dynamic patient care duties. Nurses may change infusions or medications prematurely,
to adhere to “per shift” drug/tubing change infection prevention policies. There may be
pressure to change medications earlier to accommodate breaks and expedite shift
change to stay within compliance. The timing of pharmaceuticals is a regulated process;
however, organizational issues such as the absence of labeling and shift schedules may
result in premature drug delivery systems replacements resulting in avoidable waste
(Fogarty & McKeon, 2006). (Olsen et al., 2007).
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Work Environment Factors
Not all healthcare systems develop consistent disposal and pharmaceutical
management systems, and in some situations, nurses may be overworked with higher
patient loads. To elaborate, some of these pressures within organizations include
demanding turnaround time for patient care (early discharge, higher patient loads).
These may be examples of factors that are determined at the administration level.
Medication errors are associated with heavier workloads (Fogarty & McKeon, 2006). In
some situations, there may be a nurse shortage which ultimately increases work
pressure and the number of patients per nurse. The nursing work environment may
increase medication errors due to the need for urgency in many situations, which can
create more pharmaceutical waste (Rogers, Hwang, & Scott, 2004).
Standardized Concentrations
Standardization of medications is intended to avoid error in calculations, reduce
waste, streamline inventory, and facilitate the use of Intravenous premixed solutions.
When more than one concentration is needed for medications, the standardization
typically requires another request for another drug to maintain safe handling (Beyeya,
Hicks & Beker, 2003). This causes waste due to the need for a specific amount which
may be less than or greater than the standardized concentration. Some hospitals take
part in standardizing concentrations which are intended to avoid error and reduce
waste; however, in some situations standardization does not allow individuals to choose
the exact amount of medication resulting in more waste.
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Studies in Hospital-based Settings
Nine studies were identified that modeled pharmaceutical disposal in hospitalbased settings and the implications for waste (Tables 3-5). Overall, the literature
explored measures that contribute to pharmaceutical waste volumes. The studies
showed that the most commonly wasted medications included antibiotics for Intensive
Care Units and propofol for Operating Rooms. All studies addressed the need for
improved clinical design and avoidance of waste. In one specific study exploring ICU
waste by Al-Dhawaille, researchers reported that 265 items of IV medication were
collected during the study period and antibiotics preparations (77%) were the most
unused and wasted. Medication discontinuation (60%) was the leading cause of such
wastage (Al-Dhawaille, 2011). For the operating room, a common waste theme that
emerged was the open availability and use of drugs (Abbasi & Gay, 2017).
Most studies addressed the costs of preventable waste and the importance of
exploring clinical redesign methodologies to decrease financial loss. One author stated
that in the operating room specifically, anesthetic management of surgical cases can
contribute substantially to total wastage costs; therefore careful use of these drugs was
suggested to decrease cost (Nava-Ocampo et al., 2017).
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Table 3 Matrix of Studies Exploring Unavoidable and Avoidable Waste

First Author,
Publication Year

Location

Study Design

Length of
Study

Journal
Name

Publicatio
n type

Departm
ent
Type of Facility Type of Pharmaceuticals

Atcheson, 2016

New York,
USA

Observational
Study

12 months

Journal of
Clinical
Anesthesia

Research
Support

OR

Academic
Hospital

Anesthetics

Almeida,2016

Sao Paulo,
Brazil

Observational
Study

3 months

Journal School
of Nursing

Observation
al Study

OR + ICU

University
Hospital

IV

Abbassi, 2017

Tampa,
Florida

Observational
Study

7 days

Hospital
Pharmacy

Observation
al Study

ICU

Tertiary Care
Hospital

Oral,IV

Al-Dhawallie, 2011

Riyadh,
Saudi Arabia

Observational
Study

1 month

Saudi Medical
Journal

Observation
al Study

ICU

Teaching Hospital IV
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Chaudhary, 2012

L'Hommedieu, 2010

Mankes,2012

More, 2015

India

New York,
USA

USA

India

Observational
Study

Observational
Study

Observational study

Observational study

12 months

Journal
Anaesthesiologi
cal Clinical
Observation
Pharmacologic al Study

OR

Tertiary Care
Hospital

Anesthetics

30 days

American
Journal of
Health System
Pharmacy

Observation
al Study

ICU

Children's
Hospital

IV

13 months

International
Anesthesia
Society

Brief Report

OR

Academic
Hospital

Anesthetics

3 months

Journal of
Clinical and
Diagnostic
Research

Observation
al study

OR

Tertiary Care
Hospital

Anesthetics
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Nava-Ocampo, 2004

Mexico

Observational
Study

1 year

Fundamental &
Clinical
Pharmacology

Observation
al study

OR

Tertiary Care
Hospital

Anesthetics

Table 4 Subgroup: Intensive Care Unit setting
First Author,
Publication Year

Type of Drugs

Location

Study Design

Cost of
preventable drug
waste

Length of
Study

The total value of
wasted low-cost
drugs significantly
decreased from
phase 1 to phase 2
($41 to $21 per 100
patient days; p <
.05)

Abbassi, 2017

Tampa, Florida

Observational
Study

7 days

Oral,IV

How many
cases/beds/uni
ts

Drug Analysis

517 beds

Total wasted CSPs decreased
from 97 doses wasted in phase 1
to 83 doses wasted in phase 2.
These numbers represent 2.2%
and 1.8%, respectively, of total
CSPs prepared during each
phase.
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Almeida,2016

Al-Dhawallie, 2011

Sao Paulo, Brazil

Riyadh, Saudi
Arabia

Observational
Study

Observational
Study

3 months

1 month

New York, USA

Observational
Study

30 days

356 units

Most discarded pharmacological
classes were: 22.7%
antimicrobials, 14.8%
electrolytes, 14.6%
analgesics/pain killers

--------------

430 units

265 items of IV medication were
collected during the study period.
Antibiotics preparations (77%)
were the most unused and
wasted. Medication
discontinuation (60%) was the
main cause for such wastage.

a weekly savings of
$8,197 ($426,244
annually),

500 beds

Wasted i.v. doses decreased
from 1,339 (16.6% of the total
doses dispensed) to 853 (8.6%).

IV

IV
IV

L'Hommedieu, 2010

------------

Exploring Pharmaceutical Waste Prevention and Disposal Practices in Nurse Populations 36

Table 5 Subgroup: Operating Rooms
First Author,
Publication Year

Type of Pharmaceuticals
Cost of preventable
drug waste
Location

Atcheson, 2016

Chaudhary, 2012

Mankes,2012

New York,
USA

India

Study
Design

Observatio
nal Study

Observatio
nal Study

Observatio
nal study

How many
cases/beds/units

Drug Analysis

Length of Study
Anesthetics

185,250

543 cases

Preventable waste was generated
most frequently for ephedrine
(59.5% of cases), and
succinylcholine (33.7%)

Anesthetics

The cost of wasted
drugs for the study
duration was 46.57%
$1604 of the total cost
of drugs issued/loaded
propofol was
maximum being
56.27% $928

98 cases

Maximal wastage was associated
with adrenaline and lignocaine
(100% and 93.63%, respectively).
This is accounted for maximum
wastage due to not being used after
loading into a syringe.

Anesthetics

------------------

8 operating rooms

Propofol was the most widely
dispensed and wasted drug at the
facility. And accounted for 45% of
the total drug waste by mL.
Eliminating the 50 and 100 mL
bottles of propofol reduced the
facility's propofol waste from 29.2
mL/day/bin to 2.8 mL/day/bin.

12 months

12 months

13 months

Exploring Pharmaceutical Waste Prevention and Disposal Practices in Nurse Populations 37

Anesthetics

More, 2015

Nava-Ocampo, 2004

India

Mexico

Observatio
nal study

Observatio
nal Study

The cost of wasted
drugs for study
duration was 29.82%
$1027 of the total cost
of drugs was loaded
$3445.

200 cases

Thiopentone sodium was frequently
used intravenous inducing
anesthetic agent in 75% of patients.
Amongst intravenous anesthetic
agents maximum wastage was
associated with propofol of about
36.59% and in pre-an aesthetics,
wastage was maximum for atropine
79% followed by glycopyrrolate
45.95%, pentazocine 45.95%.

The median
undocumented cost
was US$92.4 (95% CI
$17.2–$216.6) per 100
requested units.

100 units

Two specific drugs, rocuronium and
nalbuphine, were found to have the
highest waste

3 months

1 year

Anesthetics
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Chapter 3: Research Method
A cross-sectional survey was conducted in February and March of 2019 at Yale
New Haven Hospital, after approval by the Institutional Review Board at Yale University
(#2000024892). The primary method of data collection was a self-administered survey.
All surveys were entered anonymously, online, via Qualtrics survey Software (Qualtrics
Laboratories, Inc., Provo, UT, USA). Eligible participants were recruited via a secure,
anonymous link to the survey instrument. Informed consent was obtained through the
online survey that provided study information, the survey duration, participants’ rights,
and contact information for a study representation about concerns or questions.
The cross sectional survey consisted of a mix of quantitative and qualitative
aspects of the survey, including open ended questions. The survey questions were
designed to probe knowledge, behavior, and attitudes of nurses towards pharmaceutical
waste. The survey also intended to understand what types of motivations drive the
waste in the Intensive Care Unit (ICU) and Perioperative Units at Yale New Haven
Hospital. The average time taken to complete and return the survey was four minutes.
The final survey contained thirteen questions covering perception, knowledge, training,
attitudes and two open-ended questions about commonly wasted pharmaceuticals and
opportunities for waste disposal improvement. The survey questions were developed by
one Anesthesiologist, one Occupational Health Director Physician, one Medical ICU
nurse, and one Master of Public Health candidate.
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The main outcome goals of the survey were nurses’ knowledge and attitudes
towards pharmaceutical disposal practices, as well as waste prevention, and the factors
that may have influenced them. The study focused on key independent variables: a)
perception of knowledge about pharmaceutical disposal and prevention, b) attitudes
towards improper waste segregation, c) behaviors in drug disposal, and d) opportunities
for improvement. Data on predictors included gender, years of experience, and the
highest degree earned. Results from the study also offered opportunities for
improvements such as conditions that should be changed to increase compliance and
most commonly wasted drugs.

Participant Criteria
To be eligible for the study, potential participants must be 18 years or older and a
currently practicing nurse at the Yale New Haven Hospital’s Intensive Care Units or
Perioperative Care Units. Nurses could hold any of the following degrees: Licensed
Practical Nurse, Certified Prepared Registered Nurse, Advanced Prepared Registered
Nurse, Bachelor of Science in Nursing, and Master of Science Nursing. Exclusion
criteria included nursing students in the Yale New Haven Hospital Health system as well
as participants who refused to give informed consent.

Participant Recruitments
Data collection took place at the Yale New Haven Hospital Health System
(YNHH) Intensive Care Units (ICU) and Perioperative Care Units. Respondents were
recruited based on flyer distribution via message boards, and via email distribution by
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Nurse Patient Managers. Also,in-person recruitment was conducted in the Medical ICU
at Saint Rafael Campus.

Method of analysis
Study data were recorded using Qualtrics and analyzed using the Statistical
Package for Social Sciences (SPSS). Descriptive statistics of survey responses were
calculated including frequency and percentages of data. Open ended questions were
grouped and integrated with the descriptive quantitative results. To check the
association between the predictors and the dependent variable, a Kruskal-Wallis test (a
non-parametric version of ANOVA) was performed since the dependent variable was
ordinal and then an ordinal logistic regression model was generated using predictors as
the independent variable.
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Survey
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Chapter 4: Results

Demographics
Participants for the survey consisted of 122 Intensive Care Unit (ICU) (N=114)
and Perioperative nurses (N=8) from the Yale New Haven Hospital Health campuses,
York Street and Saint Raphael. Data excluded 16 participants because they had not
completed the survey past the first 2 questions, and 2 participants were not ICU or
Perioperative nurses. Thus the sample for the study was 104 survey respondents.
The demographics of the participants are included in Table 6. 61.5% of nurses
have a Bachelor’s in Nursing Science (N=64/104), and 44.2% worked as a nurse for
one to five years (N=46/104). Additionally, 77.8% of nurses were female (N=81/104),
and 83.7% of nurses (N=87/104) were ICU nurses from the Medical Intensive Care
Units
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Knowledge about Pharmaceutical Waste (Questions 1-5)
The knowledge based portion of the survey begins with a question exploring the
perception of nurses’ knowledge about pharmaceutical waste segregation. A statement
was added prior to the question that reads: “There are many types of pharmaceutical
waste streams in the hospital setting. Waste segregation refers to placing a specific
type of waste into the appropriate receptacle.” The participants were then asked about
perception and waste segregation based on a Likert scale. The results showed that
31.7% of nurses (N=33/104) either strongly agree or agree that they feel knowledgeable
about which types of pharmaceutical waste go into each bin, while 32.7% of nurses
(N=34/104) either disagree or slightly disagree with this statement.
When nurses were tested on their knowledge about which types of waste belong
to which bin, (Questions 2-4), 8.7% respondents (N=9/104) answered all three
knowledge-based questions (Questions 2-4) correctly, while 15.4% of nurses
(N=16/104) answered none of the questions correctly. Interestingly, the number of
respondents who disposed of unused and excess medicines in the trash across all three
knowledge based questions was: 8.7% (N=9/104) for p-listed drugs, 23.1% (N=24/104)
for antibiotic bags, and 23.1% (N=24/104) for unused syringes.
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Figure 4: Frequency of Accuracy in Knowledge Based Questions

The last portion explored how nurses were trained in pharmaceutical waste
management (Question 5) and 63.5% of all nurses (N= 66/104) chose “Yale New Haven
Hospital online training” and 23.1% of all nurses (N=24/104) chose “other nurses and
colleagues” as a method for education. Moreover, 19.2% of participants (N=20/104)
across all Intensive Care and Perioperative units said they never received training for
the proper and safe disposal of medications. Additionally, 9.6% (N=10/104) nurses
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offered qualitative input in the “other” category and stated that they learned about waste
disposal through some of the following ways: in-service posters, signs near bins, and
pharmacist on the floor.

Attitudes Towards Pharmaceutical Waste Prevention (Question 6)
The next part of the survey (Question 6) explores attitudes towards properly
disposal for pharmaceutical waste. Respondents could check more than one box to
indicate why they believe it is important to dispose of pharmaceutical waste correctly.
95.2% of nurses (N=99/104) indicated that it is important to dispose of pharmaceutical
waste correctly “to protect the environment,” while 1.9% of nurses (N=2/104) indicated
that they “don't believe it’s important to segregate drug waste.” Moreover, 76.0%
(N=79/104) of respondents also chose “to follow regulatory compliance” as a reason to
properly dispose of waste, while only 50.0% (N=52/104) of respondents equate the
significance of proper disposal to “saving money on drug disposal fees.”
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Behaviors in Drug Disposal (Questions 7-8)
Questions 7-8 elicit reasons contributing to improper pharmaceutical waste
disposal practices. 56.7% (N=59/104) of nurses ranked “lack knowledge” as the top
contributor to improper pharmaceutical waste disposal practice by nursing staff, while
“the lack of concern about adherence to proper waste segregation” was ranked as the
least common reason. For Question 7, the distribution of “Years of experience” is
described as followed: 49.0% of nurses (N=51/104) with “1-5 years of experience”
believe that “lack of knowledge” is the top contributor to improper waste disposal. Only
1.9% of nurses (N=2/104) %, who have “worked less than one year,” believed that the
“lack of knowledge” is the top contributor to improper waste disposal. The results
showed that nurses commonly waste: Narcotics, Intravenous Bags, and Vasopressors.
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Quality Improvement (Questions 9-10)
One of the study’s main goals was to explore methods for waste prevention.
Question 9 explored details about avoidable waste behaviors. The section begins with
the statement: “Pharmaceutical waste refers to drugs that are opened/prepared, but not
administered to a patient. Sometimes drug waste is unavoidable, e.g., if a patient gets
better and no longer needs infusions. Other times, drug waste is avoidable, meaning it
could have been prevented. The following questions refer to AVOIDABLE waste.” The
subsequent Question 9 asks about which situations create avoidable drug waste during
nursing duties. 37.5% of nurses (N=39/104) indicated that the order for medication is
less than the available package size as the top reason contributing to avoidable waste.
33.6% of nurses (N=35/104) believe that errors in provider orders or changes in
medication orders are the top cause of avoidable waste.

In terms of preventing further waste at the nurse staff level, Question 10 asked
participants to name ways conditions could be improved via an open text answer.
Nurses stated that more pharmaceutical training, better labeling on bins, and better
signage could be ways to improve compliance. The results were coded and calculated
based on most commonly mentioned. 22.7% nurses (N=30/132) requested more
training for safe disposal of medications, including during employee orientation and
annual continuing education. Furthermore, 14.4(% of nurses (N=19/132) stated there
should be disposal information on dispensed medication labels or Pyxis Machines
(machines that dispense medications at the department level), and 19.7% of nurses
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(N=26/132) mentioned there should be more signage. 22.7% of respondents
(N=30/132) agreed that better training and education could be improved to increase
proper waste segregation. Some nurses noted that they rarely go over waste
segregation at orientation and the online training do not offer guidance.
Figure 5: Situations that Create Avoidable Waste
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Associations between Predictors and Outcomes
Predictors such as gender, degree and years of experience were analyzed to find
associations between outcomes of questions. Performed Chi-square tests for binary
outcomes, ANOVA for continuous outcomes, and Kruskal-Wallis test for nonparametric
outcomes. There were not any statistically significant outcomes for any of the questions
by gender, degree, or years of experience. However, based on the results of a KruskalWallis test (a non-parametric version of ANOVA, since the dependent variable was
ordinal), the only significant predictor was “years of experience” for the questions
involving the perception of pharmaceutical waste and behaviors associated with
improper waste segregation. An ordinal logistic regression model was generated using
gender as the independent variable. However, these results were not statistically
significant since the confidence interval included 1. Though multivariate analysis
exploring the following predictors was explored, the non-statistically significant
outcomes could be due to the limitations of sample size and limited distributions of
predictors in nurses. The nature of the survey asked about knowledge, attitudes and
behaviors and “years of experience” could be a significant predictor given that the
length of experience could associate certain question outcomes. The multivariate
analysis could be further explored \ if the sample size increases, to decrease variability
across gender, years of experience, and degree.

Chapter 5: Discussion
In the United States, hospital waste management does not follow a standard
system for pharmaceuticals. The United States Environmental Protection Agency and
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Drug Enforcement Agency, along with other stakeholder agencies such as the Centers
for Disease Control and Occupational Safety and Health Administration, play a
significant role in the regulation of medical waste. However, pharmaceutical waste is
typically regulated at a state level which can result in gaps in disposal management.
Pharmaceutical waste management needs a more streamlined system. Given the
complexity of pharmaceutical disposal management at the regulatory level, adherence
to standards of proper practice at the occupational level can improve waste
management in healthcare.
The main goal of this study was to assess attitudes and knowledge gaps about
pharmaceutical waste management and to explore methods to prevent waste at the
source. This cross-sectional survey of ICU and OR nurses explored causes of excess
pharmaceutical waste as well as disposal management at the nurse level. This study
showed that nearly 56% of participants feel that the lack of knowledge is the top reason
that contributes to improper pharmaceutical waste disposal practices by nursing staff. .
The current study adds to what is already known about improper pharmaceutical
waste disposal. One study concluded that though knowledgeable health care
professionals such as nurses were trained in waste disposal methods, it did not always
translate to safely practiced drug disposal which shows that this topic should be further
explored (McCullagh et al., 2012). Like other studies, this current study demonstrated
the importance of education, and interestingly this current study showed that there is a
knowledge gap at Yale New Haven Hospital despite 63.5% of nurses (N=66/104)
indicating that they learn about pharmaceutical waste from Yale New Haven Hospital
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Training. This suggests that both the content and the frequency of the online training
should be a priority for hospitals to increase pharmaceutical compliance.
Our study uncovered potential improvements in waste disposal at the nurse
level. Hospital administration will benefit by building a culture that understands
consequences on the health and the environment. Ultimately, if the administration can
engage in fostering a clinically sustainable community, it could improve waste
management, compliance, protect the public health and save on costs. It is clear from
our study that nurses are engaged in behaviors that create avoidable waste and nurses
may not be trained in proper disposal practices. However, nurses do think their
behaviors play a role in the community given that many believe it is important to protect
the environment and public health. Leaders in healthcare could benefit from this
occupational engagement by building sustainability awareness into the hospital culture.
Awareness can include administration improvements like educational, streamlined
signage and bins throughout patient rooms and break rooms. Understanding perception
and barriers of improper medication disposal would also factor in the likelihood that
medical personnel would participate in proper disposal programs.
The improved culture that understands consequences on the health and the
environment should be cognizant of the barriers for improper medication disposal. Our
survey uncovered that poor signage and the lack of bins for disposal are some issues
that create barriers for proper disposal. It is also evident that due to the complexity of
pharmaceutical waste regulations, there is a need for more consistent training. Nurses
mentioned that orientation and online training lack explicit guidance on waste
segregation. Interestingly, our study found that 16.7% of respondents mentioned that
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they learned about waste management from other colleagues and nurses. One of the
three methods for changing social health norms is by encouraging learning through peer
behavior, making peer behavior visible, and creating peer expectations. A future action
plan should include a collaborative approach involving all nurses and administration.
The ultimate goal is to increase compliance amongst nurses and if hospitals can commit
to building a sustainable culture, awareness that revolves around nurse norms and
attitudes could create an impact.

Strengths/Limitations
The strength of this study is the exploration of nursing knowledge gaps about
proper pharmaceutical disposal management, as well as prevention of pharmaceutical
waste in hospital settings. The study also examines the implications for reducing waste
generation at the source and explores disposal processes to identify opportunities to
minimize environmental pollution. The results from the study can provide an
understanding of pharmaceutical waste management systems which will aid
constituencies to improve pharmaceutical disposal education and training. Additionally,
the exploration of nurses’ knowledge, behavior, and attitudes can guide policies to be
inclusive of barriers within pharmaceutical waste management. This study was a pilot,
and our findings provide useful data on nurse perception of relevance to the practice of
the competencies and behaviors at Yale New Haven Hospital.
The study does display some limitations. The disadvantage to cross-sectional
study design is that it includes the challenges associated with establishing a causal
inference, and the findings represent on a single time and place (Pannucci, 2010). The
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data represent a single institution. This may limit the possibility to generalize the results
of this study to other institutions (Haneuse, 2016).
Another limitation includes the survey distribution. The survey was distributed via
email, flyer, and in-person recruitment. In-person recruitment started in the Medical
Intensive Care Unit (MICU) with direct relationships with the staff. The methods for
recruitment could result in selection bias because of the exclusion of the population not
in the MICU. The survey relied on convenience sampling, and the survey may not have
reached all nurses. Any non-responders may have different levels of attitude towards
wasting pharmaceuticals. Their behavior may vary and they could be experiencing
different challenges. (Haneuse, 2016).
Since this is a pilot study, survey questions may have been ambiguous.
(Pannucci, 2010). Survey questions were developed by a team of stakeholders at Yale
New Haven Hospital (1 anesthesiologist, 1 physician, 1 RN, and 1 MPH candidate);
therefore, results and analysis of the survey questions should be taken into
consideration and may not be reflective of all knowledge, behavior, and practice
amongst nurses. Also, with responses that require recall or estimation, responses may
reflect recall bias of disposal practices. Another limitation might be that the study
represents attitudes and behaviors reported by nurses.
This survey represents nurses’ perceptions and opinions through qualitative
approaches such as a “Likert Scale” or open text option; however, the exact amount of
pharmaceutical disposal was not explored (Haneuse, 2016).Lastly, the sample size of
the survey can add a limitation to the study. The sample size resulted in 104
respondents who may not be representative. A follow-up study employing surveys with
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a quantitative assessment of pharmaceutical waste utilizing the Pyxis machine (a
machine that dispenses medications at a department level instead of a pharmacy) or
other drug tracking machines could yield more productive results

Conclusion and Future Recommendations
The survey uncovered a considerable knowledge gap in nurses’ knowledge of
pharmaceutical waste management and shed light on specific behaviors that lead to
improper disposal practices. Furthermore, the survey modeled methods for prevention
of pharmaceutical waste and improved segregation among nursing staff. The main goal
of this study was to explore waste management and utilize this evidence based
research on understanding prevention at the nurse level. Methods for improvement
included consistent and rigorous training at the departmental level and more
accessibility to bins and signage. The training and education for nurses should be
strengthened to include details about the importance of proper pharmaceutical disposal.
In the longer term, waste prevention can prove to be beneficial cost and health wise for
all communities of interest. Waste prevention allows for ongoing cost savings, increased
resource efficiency, and improved environmental credentials. With more waste
prevention and research happening at the occupational level, hospitals can take
reasonable steps to prevent and reduce waste and demonstrate their environmental
stewardship.
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Appendix A: Survey Instrument
A-D: Demographics
Questions 1-10: Survey Questions
A) Are you an ICU nurse at Yale New Haven Hospital?
●

Yes

●

No

B)Which Yale New Haven Hospital Campus do you currently work at?
●

York Street Campus

●

Saint Raphael Campus.

C)Please choose which ICU you currently work at:
●

Cardiac Intensive Care Unit

●

Cardiothoracic Intensive Care Unit

●

Medical Intensive Care Unit

●

Neonatal Intensive Care Unit

●

Neurosurgical Intensive Care Unit

●

Pediatric Intensive Care Unit

●

Surgical Intensive Care Unit

Question #1 :There are many types of pharmaceutical waste streams in the
hospital setting. Waste segregation refers to placing a specific type of waste
into the appropriate receptacle.
I feel knowledgeable about which types of pharmaceutical waste goes in each
bin:
●

Strongly Agree

●

Agree

●

Somewhat agree

●

Neither agree nor disagree
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●

Somewhat disagree

●

Disagree

●

Strongly disagree

Question #2:Unused, P-listed medications should go into which of the
following bins (CHOOSE ONE)
●

Blue Bin

●

Black Bin

●

Yellow Bin

●

Regular Trash Bin

Question #3:A partially used antibiotic bag should be disposed into which of
the following bins: (CHOOSE ONE)
●

Blue Bin

●

Black Bin

●

Yellow Bin

●

Regular Trash Bin

Question #4:If you open a new syringe from its packaging, and accidentally
drop it on the floor, which disposal bin should you use? (CHOOSE ONE)
●

Red Bin

●

Blue Bin

●

Recycling Bin

●

Regular Trash Bin

Question #4:How did you learn about pharmaceutical waste segregation?
(CHECK ALL THAT APPLY.)
●
Yale New Haven Hospital Online Training
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●

Other online training

●

Yale New Haven Hospital Environmental Services Officer

●

Other colleague/nurses

●

Nursing school

●

Other: __________

Question #5:I believe proper drug disposal is important because (CHECK ALL
THAT APPLY)
●

to protect environmental health

●

to protect public health

●

to follow regulatory compliance

●

to save money on drug disposal fees

●

I don't believe it's important to segregate drug waste

Question #6:Rank the following reasons, from MOST common (TOP) to
LEAST common (BOTTOM), that contribute to improper pharmaceutical
waste disposal practice by nursing staff. (DRAG AND DROP.)
●

Lack of knowledge about proper waste segregation

●

Lack of time to segregate waste

●

Lack of availability/convenient location of appropriate waste bins

●

Lack of concern about adherence to proper waste segregation

●

Other: __________

Question #7:Name one way conditions could be improved to increase proper
waste segregation compliance among nursing staff
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Question #8:Pharmaceutical waste refers to drugs that are opened/prepared,
but not administered to a patient. Sometimes drug waste is unavoidable, e.g.,
if a patient gets better and no longer needs infusions. Other times, drug waste
is avoidable, meaning it could have been prevented. The following questions
refer to AVOIDABLE waste.
Question #9:What situation, ranked from MOST common (TOP) to LEAST
common (BOTTOM), creates AVOIDABLE drug waste during nursing duties?
(DRAG AND DROP.)
●

Error in provider order/Change in medication order

●

Order for medication is less than available package size

●

Expiration of an open drug (bag or syringe)

●

Time/production pressure leading to changing infusions prematurely

●

Lack of concern about wasteful practices

Question #10:What are the most common medications you find yourself
wasting?
D):Gender
●

Female

●

Male

●

Other

●

Choose not to respond

E):How long have you worked as a nurse?
●

Less than 1 year

●

1-5 years

●

5-10 years

●

10+ years

F):What is your highest degree?
●

LPN

●

Certificate Prepared RN
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●

Associates Prepared RN

●

BSN

●

MSN
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Appendix B: Figures
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Figure 4: Frequency of Accuracy in Knowledge Based Questions
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Figure 5: Situations that Create Avoidable Waste
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Appendix C:Tables
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Table 2: Pharmaceutical Waste Treatment and Disposal (Stericycle 2018 and EPA 2017):
Table 2: Pharmaceutical Waste Treatment and Disposal (Stericycle 2018 and EPA 2017):
Method

Incineration

Description

Environmental/Health
Impact

The burning of waste at
high temperatures (800900 °C) under oxygenstarved conditions.

Residual ash is land-filled,
and can cause soil, air and
water contamination.
Water emissions occur
when wet scrubbers are
employed to remove
particulates
Burning of fossil fuels can
result in air pollution (e.g.,
particulate matter 2.5)

Capital Costs

$2.2/kg to $4.4/kg

Handling for Each Type of Drug

Bulk and Trace Chemotherapy
Pharmaceuticals
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Autoclaving

The steam heat of at
least 121°C, combined
with pressure are used
to destabilize drugs and
decontaminate
associated sharps (e.g.,
needles).

After autoclaving, waste
goes to landfill. Waste can
result in soil and land
contamination through
leaching of residual
compounds.

$36,000– $889,000

Red Bag (Non-pathology)
Red Sharps (Needle Bag)

$600,000

Bulk and Trace Chemotherapy
Pharmaceuticals

Contamination of water can
Heat transfer penetrates occur from effluent.
the waste load.
Shredding will increase
the exposure of waste to
treatment, render sharps
“unrecoverable,” as well
as reduce waste volume.
***Byproduct can be
landfilled

Microwave

This process uses
radiant energy to heat
moisture within the
waste and/or heat water
that is added to the
waste. Microwaving units
kill infectious agents and
drugs through heat and
pressure, not as a result
of exposure to the
microwaves.

After microwaving, waste
goes to landfill. Waste can
result in soil and land
contamination through
leaching of residual
compounds.
.
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Chemical Treatment

Chemicals are
introduced into a
sterilization chamber.
With proper exposure
conditions, waste is
sterilized before going to
landfill

Sewage treatment
processes can be
negatively impacted by
residual chemical
compounds in waste water
effluent.
.
With some chemical
systems there is potential
soil contamination in
landfills.

Landfill

Landfills place waste
directly into a land
disposal site without
prior treatment or
preparation. Three types
of landfill:
1)Open uncontrolled
non-engineered dump

“One half of available
--------carbon is converted to
methane during
degradation. Methane is 25
times more destructive to
the ozone layer than carbon
dioxide.”

2)Engineered landfill
3) Highly engineered
sanitary landfill

Landfill must be monitored
to prevent contamination of
ground water.
Must remove materials
containing lead and
mercury from landfills to
decrease leachate in soil
and water

30,000-450,000

Bulk and Trace Chemotherapy
Pharmaceuticals

Red Bag (Non-pathology)
Red Sharps (Needle Bag)
Municipal Trash
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Table 3 Matrix of All Studies Exploring Unavoidable and Avoidable Waste
First Author,
Publication Year

Location

Length of
Study Design Study

Journal
Name

Publication
type

Department

Type of Facility

Type of
Pharmaceuticals

New York, USA

Observational
Study

12 months

Journal of
Clinical
Anesthesia

Research
Support

OR

Academic Hospital

Anesthetics

Almeida,2016

Sao Paulo, Brazil

Observational
Study

3 months

Journal
School of
Nursing

Observational
Study

OR + ICU

University Hospital

IV

Abbassi, 2017

Tampa, Florida

Observational
Study

7 days

Hospital
Pharmacy

Observational
Study

ICU

Tertiary Care
Hospital

Oral,IV

Al-Dhawallie, 2011

Riyadh, Saudi
Arabia

Observational
Study

1 month

Saudi Medical
Journal

Observational
Study

ICU

Teaching Hospital

IV

12 months

Journal
Anaesthesiolo
gical Clinical
Pharamcologi
cs

Observational
Study

OR

Tertiary Care
Hospital

Anesthetics

Atcheson, 2016

Chaudhary, 2012

India

Observational
Study
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L'Hommedieu, 2010

Mankes,2012

More, 2015

Nava-Ocampo, 2004

New York, USA

Observational
Study

USA

Observational
study

India

Mexico

Observational
study

Observational
Study

30 days

American
Journal of
Health
System
Pharmacy

Observational
Study

ICU

Children's Hospital

IV

13 months

International
Anesthesia
Society

Brief Report

OR

Academic Hospital

Anesthetics

3 months

Journal of
Clinical and
Diagnostic
Research

Observational
study

OR

Tertiary Care
Hospital

Anesthetics

1 year

Fundamental
& Clinical
Pharmacolog
y

Observational
study

OR

Tertiary Care
Hospital

Anesthetics
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Table 4 Subgroup Analysis: Intensive Care Units
First Author,
Publication Year

Type of Drugs

Location

Abbassi, 2017

Almeida,2016

Tampa, Florida

Sao Paulo,
Brazil

Study Design

Observational
Study

Observational
Study

Length of
Study

7 days

3 months

How many
cases/bed
s/units

Drug Analysis

The total value of
wasted low-cost
drugs significantly
decreased from
phase 1 to phase 2
($41 to $21 per 100
patient days; p <
.05)

517 beds

Total wasted CSPs decreased from 97
doses wasted in phase 1 to 83 doses
wasted in phase 2. These numbers
represent 2.2% and 1.8%, respectively, of
total CSPs prepared during each phase.

------------

356 units

Most discarded pharmacological classes
were: 22.7% antimicrobials, 14.8%
electrolytes, 14.6% analgesics/pain killers

Cost of
preventable drug
waste

Oral,IV

IV
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Riyadh,
Al-Dhawallie, 2011 Saudi Arabia

Observational
Study

1 month

New York,
USA

Observational
Study

30 days

430 units

265 items of IV medication were collected
during the study period. Antibiotics
preparations (77%) were the most unused
and wasted. Medication discontinuation
(60%) was the main cause for such
wastage.

a weekly savings of
$8,197 ($426,244
annually),

500 beds

Wasted i.v. doses decreased from 1,339
(16.6% of the total doses dispensed) to 853
(8.6%).

IV
IV

L'Hommedieu,
2010

--------------
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Table 5 Subgroup Analysis: Operating Rooms
First Author,
Publication
Year
Locatio
n

Atcheson,
2016

Chaudhary,
2012

Mankes,2012

New
York,
USA

India

Study Design

Observational
Study

Observational
Study

Observational
study

Type of
Pharmaceutical
s

How
many
cases/bed
s/units

Drug Analysis

Cost of preventable drug
waste

Anesthetics

185,250

543 cases

Preventable waste was
generated most frequently for
ephedrine (59.5% of cases),
and succinylcholine (33.7%)

Anesthetics

The cost of wasted drugs
for the study duration was
46.57% $1604 of the total
cost of drugs
issued/loaded propofol
was maximum being
56.27% $928

98 cases

Maximal wastage was
associated with adrenaline and
lignocaine (100% and 93.63%,
respectively). This is accounted
for maximum wastage due to
not being used after loading
into a syringe.

Anesthetics

------------------

8
operating
rooms

Propofol was the most widely
dispensed and wasted drug at
the facility. and accounted for
45% of the total drug waste by
mL. Eliminating the 50 and 100
mL bottles of propofol reduced
the facility's propofol waste
from 29.2 mL/day/bin to 2.8
mL/day/bin.

Length of
Study

12 months

12 months

13 months
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Anesthetics

More, 2015

NavaOcampo, 2004

India

Mexico

Observational
study

Observational
Study

The cost of wasted drugs
for study duration was
29.82% $1027 of the total
cost of drugs was loaded
$3445.

200 cases

Thiopentone sodium was
frequently used intravenous
inducing anaesthetic agent in
75% of patients.Amongst
intravenous anaesthetic agents
maximum wastage was
associated with propofol of
about 36.59% and in preanaesthetics, wastage was
maximum for atropine 79%
followed by glycopyrrolate
45.95%, pentazocine 45.95%.

The median
undocumented cost was
US$92.4 (95% CI $17.2–
$216.6) per 100 requested
units.

100 units

Two specific drugs, rocuronium
and nalbuphine, were found to
have the highest waste

3 months

1 year

Anesthetics
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Table 6 Demographics

Gender

Highest Degree

Years of experience

N= 104

Value (%)

Female

81

77.9

Male

17

16.3

Other

2

1.9

Choose no to respond

4

3.8

BSN

66

63.5

MSN

21

20.2

APRN

11

2.9

LPN

3

2.9

CPN

3

10.6

Less than 1 year

4

3.8

1-5 years

46

44.2
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5-10 years

31

29.8

More than 10 years

23

22.1

York Street

75

72.1

Saint Raphael

29

27.9

ICU

98

94.2

Perioperative

6

5.7

Type of Perioperative Nurse

Intra-OP

6

100

Type of ICU Nurse

Medical ICU

87

83.7

Cardiothoracic ICU

12

11.5

Pediatric ICU

3

2.9

Cardiac ICU

2

1.9

Yale New Haven Campus

ICU Nurse or Perioperative Nurse
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Table 11: Pharmaceutical waste segregation training

Table 12: Knowledge about which types of pharmaceutical waste goes into each bin
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Table 13: Knowledge-based Q1- P listed medications

Table 14: Knowledge-based Q2- Antibiotic Bag
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Table 15: Knowledge-based Q3- New Syringe

Table 16: Importance of Drug Disposal
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Table 17: How conditions could improve
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Table 18:Reasons that contribute to improper waste disposal
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Table 19: Situation creates avoidable waste
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Table 20: Most common medications

